Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Cancer Prevention Portal

Cancer-Prevention-Portal-1000x250px

Cancer prevention requires public policies and actions to reduce the risk of developing cancer.

Cancer prevention includes public policies based on scientific evidence, education on prevention and healthy lifestyles, and actions taken to reduce the risk of developing cancer.

ESMO promotes cancer prevention within its mission to improve the quality of cancer care and reduce the number of deaths from cancer.  The global cancer burden is expected to rise to 29.5 million cases and 16 million deaths by 2040, making it necessary to intensify cancer prevention efforts to bring those numbers down. If 40% of cancers are preventable, then theoretically we can reduce the number of new cases in the next 20 years from 29.5 million to 17.8 million, saving almost 12 million lives.

Both the World Health Organization (WHO) and its specialised cancer agency, the International Agency for Research on Cancer (IARC), provide evidence-based research and guidance on the causes of cancer and how to prevent it.

WHO has published its first-ever WHO Report on Cancer: Setting priorities, investing wisely and providing care for all, to raise awareness that cancer is a preventable and controllable public health priority globally, and there are effective public health strategies for evidence-based decision-making.

Every 5 years, IARC publishes its World Cancer Report: Cancer Research for Cancer Prevention, emphasising that prevention offers the most cost-effective long-term strategy for cancer control. The IARC report provides the most up-to-date science on cancer, while the WHO report indicates how that science can be translated into public policies. 

Science

A collection of resources to understand the science behind cancer prevention.

Read more

Education

ESMO education material to help stakeholders to better understand cancer prevention.

Read more

Policy and Regulations

Highlights recommendations for public policies on cancer prevention from European institutions, the IACR, the WHO, and other organisations.

Read more

Patient Resources

A series of resources produced by ESMO and independent sources to address patient concerns regarding biosimilars.

Read more

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings